Cite
HARVARD Citation
Naing, A. et al. (2022). Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study. Journal for immunotherapy of cancer. 10 (3), p. . [Online].